On Being an “African American Scientist”

If African American researchers are ever to gain equal opportunities in science, even subtle cases of differential treatment must be stamped out.

Written byRaynard S. Kington
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

COURTESY OF RAYNARD S. KINGTONA recent occurrence reminded me of the challenges of identity and experience in science. Two years ago, after leaving my job as deputy director of the National Institutes of Health (NIH) to assume the presidency of Grinnell College, I was senior author of a Science paper about differential funding rates between African American and white applicants for NIH grants. Our paper demonstrated that African American scientists are significantly less likely than their white counterparts to receive NIH funding, even when they are similarly qualified.

Our study generated much media attention; and in every news interview I gave on this topic I made two points. First, while our findings suggested that the NIH review system might contain an anti–African American bias that warranted further analysis, I did not believe that review bias, if confirmed, was the major driver of the differential funding rates between African American and white applicants. Second, I emphasized my belief that funding differences were instead more likely to reflect subtle and insidious, if unintentional, differences in the experiences of African American scientists.

And so I was dismayed by a recent news story on www.the-scientist.com about our report that seemed to prove our point about the existence of such unintentional bias. The story identified me as an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies